rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

John Cochran

Director

Company insider

Files Form 4 as: Director, Aquestive Therapeutics; Chief Operating Officer, Crestline Lending Solutions.

Every Form 4 they filed

In numbers

Trades disclosed
17
Buys
1
Sells
0
Bought
$150K
Sold
$0
Companies
2
Companies where not an officer
1
First trade
24 Jul 2018
Last trade
21 Oct 2026
Last filed
23 Oct 2026

Companies traded

Where they are an officer
Crestline Lending SolutionsOfficer · last 24 Jul 20261 buy · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
AQST Aquestive TherapeuticsDirector · Pharmaceuticals · last 21 Oct 20260 buys · 0 sells

Activity over time

1 Jul – 1 Oct
011 Jul1 Aug1 Sep1 Oct

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
21 Oct 2026filed 23 Oct 2026AQST Aquestive TherapeuticsPharmaceuticalsSEC FORM 4 Code J—62,229 at $0.00filing
24 Jul 2026filed 28 Jul 2026Crestline Lending SolutionsSEC FORM 4 Bought$150K7,643.12 at $19.63filing
10 Jun 2026filed 12 Jun 2026AQST Aquestive Therapeuticsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—50,500 at $0.00filing
10 Jun 2026filed 12 Jun 2026AQST Aquestive Therapeuticsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—50,500 at $0.00filing
11 Jun 2025filed 12 Jun 2025AQST Aquestive Therapeuticsoption or derivative · PharmaceuticalsSEC FORM 4 Code A$143K42,000 at $3.41filing
20 Jun 2024filed 21 Jun 2024AQST Aquestive Therapeuticsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—38,000 at $0.00filing
21 Jun 2023filed 23 Jun 2023AQST Aquestive Therapeuticsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—25,000 at $0.00filing
22 Jun 2022filed 24 Jun 2022AQST Aquestive Therapeuticsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—25,000 at $0.00filing
15 Jun 2021filed 17 Jun 2021AQST Aquestive Therapeuticsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—20,000 at $0.00filing
10 May 2021filed 1 Jun 2021AQST Aquestive TherapeuticsPharmaceuticalsSEC FORM 4 Code G—37,500 at $0.00filing
12 Mar 2021filed 16 Mar 2021AQST Aquestive TherapeuticsPharmaceuticalsSEC FORM 4 Code J—23,038 at $0.00filing
12 Mar 2021filed 16 Mar 2021AQST Aquestive TherapeuticsPharmaceuticalsSEC FORM 4 Code J—8,228 at $0.00filing
12 Mar 2021filed 16 Mar 2021AQST Aquestive TherapeuticsPharmaceuticalsSEC FORM 4 Code J—11,544 at $0.00filing
12 Mar 2021filed 16 Mar 2021AQST Aquestive TherapeuticsPharmaceuticalsSEC FORM 4 Code J—19,091 at $0.00filing
16 Jun 2020filed 18 Jun 2020AQST Aquestive Therapeuticsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—14,000 at $0.00filing
13 Jun 2019filed 17 Jun 2019AQST Aquestive Therapeuticsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—13,350 at $0.00filing
24 Jul 2018filed 26 Jul 2018AQST Aquestive Therapeuticsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—26,700 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed1

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.